NCT02471131View on ClinicalTrials.gov

WATCHMAN Implantation During Hybrid Ablation

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Atrial FibrillationStroke
Interventions
DEVICE

WATCHMAN Device implantation

The implantation of the device will be done into the left atrial appendage according to the guidelines.

Trial Locations (1)

6229HX

Maastricht University Medical Center, Maastricht

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Maastricht University Medical Center

OTHER